NCT04636801 · Interventional trial
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)
Overall registry status Terminated
Phase 3
Conditions Chronic Obstructive Pulmonary Disease
Delaware Valley sites
- Chiesi Clinical Trial - Site 840483 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory